WIRED is where tomorrow is realized. It is the essential source of information and ideas that make sense of a world in constant transformation. The WIRED conversation illuminates how technology is ...

Lily Chee is a New York based Actress, Model and Social Media Personality. Lily has worked on numerous productions as an actress and model. Lily was discovered at age 10, after her soccer game by her ...

Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity. The proposal ...

Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs. The latest investment ...

Eli Lilly and Novo Nordisk dominate the market for weight loss drugs, and demand for their products has surpassed supply in recent times. Lilly’s weight loss portfolio has already delivered ...

At just 17, Lily Yohannes has the soccer world at her feet. Considered one of most exciting talents in the women’s game, she is already a regular in Ajax’s first-team and is making waves on ...

Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters. In a study sponsored by Lilly ...

Lilly estimates that about 20% of people in the U.S., or 63 million individuals, deal with high levels of Lp(a), which can greatly increase the risk of heart attack and lead to other ...

Copyright 2024 The Associated Press. All Rights Reserved. David Ricks, chair and CEO of Eli Lilly, fields a question during an announcement of the company’s $3 ...

"She's incredibly talented. I'm very proud," the actress said of 070 Shake's new album launch Allen Berezovsky/Getty Lily-Rose Depp is happy in love with 070 Shake. The Nosferatu actress ...

One of Eli Lilly's potential competitors in the weight loss market just reported unimpressive trial results. The company could benefit from the government coverage of its weight loss medicines.

It is tailored to patients being treated with Lilly's oncology drugs – which include blockbuster CDK 4/ 6 inhibitor Verzenio (abemaciclib) for hormone receptor-positive, HER2-negative breast ...